InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by MARGOLIN YAEL. Officer active across 1 company, notably POINT Biopharma Global Inc.. In total, 2 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €11k. Activity tracked since 21 November 2022. The latest transaction was filed on 21 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations